Crystal structure of chlorido­(2-{1-[2-(4-chloro­phen­yl)hydrazin-1-yl­idene-κN]eth­yl}pyridine-κN)(η⁵-penta­methyl­cyclo­penta­dien­yl)rhodium(III) chloride

The title compound, [Rh(η⁵-C₅Me₅)Cl(C₁₃H₁₂ClN₃)]Cl, is chiral at the metal and crystallizes as a racemate. Upon coordination, the hydrazinyl­idene­pyridine ligand is non-planar, an angle of 54.42 (7)° being observed between the pyridine ring and the aromatic ring of the [2-(4-chloro­phen­yl)hydrazin-1-yl­idene]ethyl group.

Crystal structure of langbeinite-related Rb_0.743K_0.845Co_0.293Ti_1.707(PO₄)₃

Single crystals of the langbeinite-related phosphate Rb_0.743K_0.845Co_0.293Ti_1.707(PO₄)₃ have been prepared by crystallization of high-temperature self-flux K₂O–Rb₂O–P₂O₅–TiO₂–CoO.

Crystal structure of N-{N-[N-acetyl-(S)-leuc­yl]-(S)-leuc­yl}norleucinal (ALLN), an inhibitor of proteasome

The crystal structure of ALLN, the tripeptidic inhibitor of proteasomes, is solved from synchrotron diffraction data. An infinite β-sheet extended through the crystal is formed by symmetry-related oligopeptide mol­ecules in extended conformation.

Crystal structure of 1,1′-[imidazolidine-1,3-diylbis(methyl­ene)]bis­(naphthalen-2-ol)

The crystal structure of the title compound displays a twist conformation of the imidazolidine ring with two (2-hy­droxy­naphthalen-1-yl)methyl substituents stabilized by two intra­molecular O—H⋯N hydrogen bonds.

Crystal structure of N¹-phenyl-N⁴-[(E)-(pyren-1-yl)methyl­idene]benzene-1,4-di­amine

The title compound is non-planar, with the mean plane of the pyrene ring system and the terminal N-phenyl ring being inclined to the central p-phenyl­enedi­amine ring by 29.34 (4) and 43.43 (7)°, respectively. In the crystal, mol­ecules are linked by a number of weak N—H⋯π, C—H⋯π and π–π inter­actions [inter-centroid distances = 3.5569 (11)–3.708 (1) Å], forming slabs lying parallel to (30).

Crystal structures of 2,3-bis­(4-chloro­phen­yl)-1,3-thia­zolidin-4-one and trans-2,3-bis­(4-chloro­phen­yl)-1,3-thia­zolidin-4-one 1-oxide

In the related title compounds, (1) and (2), the 3-thia­zolidine ring pucker is twisted on the S—C_methine bond in (1), while in (2), the ring has an envelope conformation with the S atom as the flap. In the crystal of (1), mol­ecules are linked by C—H⋯O hydrogen bonds forming chains along [100], while in the crystal of (2), mol­ecules are linked by C—H⋯O and C—H⋯Cl hydrogen bonds forming slabs parallel to (001).

Crystal structure of hepta­guanidinium nona­hydrogen bis­[α-hexa­molybdoplatinate(IV)] hepta­hydrate

A compound, (CH₆N₃)₇H₉[PtMo₆O₂₄]₂·7H₂O, containing the well-known Anderson-structure heteropolyoxomolybdate, was obtained by recrystallization of its powdered guanidinium salt. The protonated O atoms in the polyanion were confirmed by electron-density maps, inter­polyanion hydrogen bonds and bond-valance sums (BVS).

Crystal structure and luminescent properties of [1-(bi­phenyl-4-yl)-1H-imidazole-κN³]di­chloridozinc

A new imidazole-based zinc complex, synthesized using hydro­thermal methods, exhibits luminescent behaviour.

Crystal structure of (S)-2-[(3S,8S,9S,10R,13S,14S,17R)-3-hy­droxy-10,13-di­methyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetra­deca­hydro-1H-cyclo­penta[a]phenanthren-17-yl]-N-meth­oxy-N-methyl­pro­pan­amide (Fernholz Weinreb amide)

In research towards new antagonists against the Liver X receptor, the important inter­mediate Fernholz acid Weinreb amide has been synthesized and characterized.

Crystal structure of the mixed-metal thio­phosphate Nb_1.18V_0.82PS₁₀

The mixed-metal thio­phosphate Nb_1.18V_0.82PS₁₀ has been prepared by the use of a halide flux and the crystal structure has been analyzed by single-crystal diffraction methods.

Crystal structure of disodium 2-amino-6-oxo-6,7-di­hydro-1H-purine-1,7-diide hepta­hydrate

In the title compound, the deprotonated guanine mol­ecules are arranged in centrosymmetric pairs, and form hydrogen bonds with the neighboring water mol­ecules.

Crystal structure of bis­[1-(2-hy­droxy­eth­yl)-2-methyl-5-nitro-1H-imidazole-κN³]silver(I) tetra­fluorido­borate methanol monosolvate

1-(2-Hy­droxy­eth­yl)-2-methyl-5-nitro-1H-imidazole (metronidazole, MET) reacts with AgBF₄ to give [Ag(MET)₂]BF₄, in which the Ag atom is coordinated by two MET ligands with a trans arrangement.

Crystal structure of cis-aqua­chlorido­bis­(1,10-phenanthroline-κ²N,N′)chromium(III) tetra­chlorido­zincate monohydrate from synchrotron data

The Cr^III ion in the title complex is coordinated by two 1,10-phenanthroline (phen) ligands, one water mol­ecule and a chloride in a cis geometry, displaying a distorted octa­hedral environment. The [ZnCl₄]²⁻ anion has a slightly distorted tetra­hedral coordination geometry.

Crystal structure of (18-crown-6)potassium(I) [(1,2,3,4,5-η)-cyclo­hepta­dien­yl][(1,2,3-η)-cyclo­hepta­trien­yl]cobalt(I)

The reaction of bis­(anthracene)cobaltate(−I) with excess cyclo­hepta­triene, C₇H₈, resulted in a new 18-electron cobaltate containing two different seven-membered ring ligands, based on single-crystal X-ray diffraction. This compound is of inter­est as the first to possess cyclo­hepta­trienyl and cyclo­hepta­dienyl ligands in an anionic metal complex.

Crystal structure of 2-benzyl­amino-4-(4-bromo­phen­yl)-6,7-di­hydro-5H-cyclo­penta­[b]pyridine-3-carbo­nitrile

The packing of the title compound features N—H⋯N hydrogen bonds, which form inversion dimers, and weak aromatic π–π stacking inter­actions.

Synthèse et structure cristalline d'un matériau noir AgMn^II₃(Mn^III_0,26Al_0,74)(MoO₄)₅

A new silver aluminium trimangan­ese penta­molybdate, AgMn^II₃(Mn^III_0,26Al_0,74)(MoO₄)₅, is composed of M₂O₁₀ dimers, M₃O₁₄ (M = Mn, Al) trimers and MoO₄ tetra­hedra sharing corners and forming three types of layers. A comparative structural description is provided with the structures of related phases containing dimers, trimers and tetra­mers.

Crystal structures of two hydrazinecarbo­thio­amide derivatives: (E)-N-ethyl-2-[(4-oxo-4H-chromen-3-yl)methyl­idene]hydrazinecarbo­thio­amide hemi­hydrate and (E)-2-[(4-chloro-2H-chromen-3-yl)methyl­idene]-N-phenyl­hydrazinecarbo­thio­amide

The title compounds, (I) and (II), are hydrazinecarbo­thio­amide derivatives. In the crystal of (I), two independent mol­ecules are linked by bifurcated N—H⋯O and C—H⋯O hydrogen bonds, forming two (6) ring motifs, and (10) and (14) ring motifs. In the crystal of (II), mol­ecules are linked by pairs of N—H⋯S hydrogen bonds, forming inversion dimers with an (8) ring motif.

Crystal structure of {(but-3-en-1-yl)bis­[(pyridin-2-yl)meth­yl]amine-κ³N,N′,N′′}di­chlorido­copper(II) di­ethyl ether hemisolvate

The hemi-diethyl etherate of the square pyramidal copper complex, 1-butene-bis­(pyridin-2-ylmeth­yl)amine copper(II) chloride is reported. The basal plane consists of the three nitro­gen atoms from the ligand and one chlorine. The second chlorine occupies the apical position of the square pyramid.

Crystal structure of the di-Mannich base 4,4′-di­chloro-3,3′,5,5′-tetra­methyl-2,2′-[imidazolidine-1,3-diylbis(methyl­ene)]diphenol

In the title compound, the imidizadoline ring adopts an envelope conformation and the nitro­gen lone pairs are oriented in a syn disposition. The crystal packing is stabilized by C—H⋯O hydrogen-bonding inter­actions.

Crystal structure of 4-methyl-N-[(4-methyl­pyridin-2-yl)carbamo­thioyl]­benzamide

In the title compound, C₁₅H₁₅N₃OS, intra­molecular N—H⋯O and C—H⋯S hydrogen bonds both generate S(6) rings. The C=O and C=S bonds lie to opposite sides of the mol­ecule. In the crystal, inversion dimers linked by pairs of N—H⋯S hydrogen bonds generate (8) loops.

Structure cristalline du composé intermétallique Ni₁₈Ge₁₂

The title compound was synthesized using solid-state reaction and characterized by X-ray diffraction. The structure crystallizes in an own structure type which is a commensurate superstructure of an underlying B8-type substructure.

Crystal structure of tetra­aquabis(1,3-di­methyl-2,6-dioxo-3,7-di­hydro-1H-purin-9-ido)magnesium

The title complex, [Mg(C₇H₇N₄O₂)₂(H₂O)₄], lies across an inversion centre and the Mg^II atom is coordinated in a slightly distorted octa­hedral environment by four aqua ligands in the equatorial sites and imidazole ring N atoms in the axial sites. In the crystal, O—H⋯O and O—H⋯N hydrogen bonds link complex mol­ecules, forming a three-dimensional network incorporating (8) and (18) graph-set motifs.

Crystal structure of bis­(μ₂-4-tert-butyl-2-formyl­phenolato)-1:2κ³O¹,O²:O¹;3:4κ³O¹,O²:O¹-bis­(4-tert-butyl-2-formyl­phenolato)-2κ²O¹,O²;4κ²O¹,O²-di-μ₃-methoxido-1:2:3κ³O;1:3:4κ³O-di-μ₂-methoxido-1:4κ²O;2:3κ²O-tetra­copper(II)

The dinuclear title compound crystallizes as a dimer forming a tetra­nuclear copper(II) complex, [Cu₄(CH₃O)₄(C₁₁H₁₃O₂)₄], in the solid state. In this complex, all Cu^II atoms have a square-pyramidal coordination sphere, with long axial and short basal Cu—O distances.

Crystal structure of 1-bromo-2-(phenyl­selen­yl)benzene

The first crystal structure determination of 1-bromo-2-(phenyl­selen­yl)benzene is presented. The mol­ecules form weak dimers through displaced parallel π-stacking inter­actions.

Crystal structure study of a cobaltoan dolomite from Kolwezi, Democratic Republic of Congo

Crystal structure of catena-poly[silver(I)-μ-L-tyrosinato-κ²O:N]

Crystal structure of catena-poly[[tri­methyl­tin(IV)]-μ-2-(2-nitro­phen­yl)acetato-κ²O:O′]

Crystal structure of [1-(2,6-diiso­propyl­phen­yl)-2,4-bis­(di­methyl­amino)-5-tri­methyl­silyl-1,3,5-tri­aza­penta­dienyl-κ²N¹,N⁵](tri­phenyl­phosphane-κP)copper(I)

Crystal structure of di­aqua­(μ₂-tri­ethyl­ene­tetra­minehexa­acetato)­dizinc tetra­hydrate

Crystal structure of bis­(1-methyl-1H-imidazole-κN³)(5,10,15,20-tetra­phenyl­porphyrinato-κ⁴N)iron(II)–1-methyl-1H-imidazole (1/2)

Tetra­aqua­bis­[2-(2-nitro­phen­yl)acetato-κO]cobalt(II)

Crystal structure of [1,3-bis­(di­phenyl­phosphan­yl)propane-κ²P,P′](N,N′-di­methyl­thio­urea-κS)(thio­cyanato-κN)copper(I)

Crystal structure of bis­[S-hexyl 3-(4-methyl­benzyl­idene)di­thio­carbazato-κ²N³,S]palladium(II)

Crystal structure of chlorido­(2-{[2-(4-chloro­phen­yl)hydrazin-1-yl­idene-κN¹](phen­yl)meth­yl}pyridine-κN)(η⁵-penta­methyl­cyclo­penta­dien­yl)iridium(III) tetra­phenyl­borate

Crystal structure of 2,2′-bi­pyridine-1,1′-diium tetra­chlorido­zincate

Crystal structure of tri­chlorido­(4′-ferrocenyl-2,2′:6′,2′′-terpyridine-κ³N,N′,N′′)iridium(III) aceto­nitrile disolvate

Crystal structure of bis­(η⁵-cyclo­penta­dien­yl)(1,4-di-tert-butyl­buta-1-en-3-yn-1-yl)zirconium(IV) μ₂-hydroxido-bis­[tris­(penta­fluoro­phen­yl)borate]

Crystal structure of di­aqua­[5,10,15,20-tetra­kis­(4-bromo­phen­yl)porphyrinato-κ⁴N]magnesium

Crystal structure of ethyl 1′,1′′-di­methyl-2′′,3-dioxo-3H-di­spiro­[benzo[b]thio­phene-2,3′-pyrrolidine-2′,3′′-indoline]-4′-carboxyl­ate

Crystal structure of rac-3-hy­droxy-2-(p-tol­yl)-2,3,3a,4,7,7a-hexa­hydro-1H-4,7-methano­isoindol-1-one

Crystal structure of 4-{[(naphthalen-2-yl)sulfonyl­amino]­meth­yl}cyclo­hexa­necarb­oxy­lic acid

Crystal structure of (3S)-3-acet­oxy-17-(pyridin-3-yl)androsta-5,16-diene

Crystal structure of ethyl 2′′,3-dioxo-7′,7a'-di­hydro-1′H,3H,3′H-di­spiro[benzo[b]thio­phene-2,6′-pyrrolo­[1,2-c]thia­zole-5′,3′′-indoline]-7′-carboxyl­ate

Crystal structure of 15-(naphthalen-1-yl)-7,7a,8,9,10,11-hexa­hydro-6a,12a-(methano­epoxy­methano)­indolizino[2,3-c]quinoline-6,13(5H)-dione

Crystal structure of ethyl 1′,5-di­methyl-2′′,3-dioxo-3H-di­spiro­[benzo[b]thiophene-2,3′-pyrrolidine-2′,3′′-indoline]-4′-carboxyl­ate

Crystal structure of 3-[2-(thio­phen-3-yl)ethyn­yl]-2H-chromen-2-one

Crystal structure of ethyl 5′′-fluoro-2′′,3-dioxo-6′,7′,8′,8a'-tetra­hydro-2′H,3H,5′H-di­spiro­[benzo[b]thio­phene-2,1′-indol­izine-3′,3′′-indoline]-2′-carboxyl­ate

Crystal structure of 2-methyl­amino-3-nitro-4-p-tolyl­pyrano[3,2-c]chromen-5(4H)-one

Crystal structure of (Z)-2-(1-benzyl-2-oxoindolin-3-yl­idene)-N-phenyl­hydra­zine-1-carbo­thio­amide

Crystal structure of pseudoguainolide

Crystal structure of 4-bromo­anilinium 4-methyl­benzene­sulfonate

Crystal structure of di­ethyl 2,2′-[((1E,1′E)-{[(1R,4R)-cyclo­hexane-1,4-di­yl]bis­(aza­nylyl­idene)}bis­(methanylyl­idene))bis­(1H-pyrrole-2,1-di­yl)]di­acetate

Crystal structure of 5-(1,3-di­thian-2-yl)-2H-1,3-benzodioxole

Crystal structure of N-[4-amino-5-cyano-6-(methyl­sulfan­yl)pyridin-2-yl]-2-chloro­acetamide

Crystal structure of N-[4-amino-5-cyano-6-(methyl­sulfan­yl)pyridin-2-yl]acetamide hemihydrate

Crystal structure of 1-(2-chloro­acet­yl)-3,3-di­methyl-2,6-di-p-tolyl­piperidin-4-one

Crystal structure of 3-[(4-benzyl­piperazin-1-yl)meth­yl]-5-(thio­phen-2-yl)-2,3-di­hydro-1,3,4-oxa­diazole-2-thione

Crystal structure of (4Z)-4-{[(2-chloro­phen­yl)amino](furan-2-yl)methyl­idene}-3-methyl-1-phenyl-4,5-di­hydro-1H-pyrazol-5-one

Crystal structure of 2-(3-bromo­phen­yl)-1,3-di­thiane

Crystal structure of 2-(3-nitro­phen­yl)-1,3-di­thiane

Crystal structure of 1-butyl-2,3-di­methyl­imidazolium dicarba-7,8-nido-undeca­borate

Crystal structure of 2-[(3S,4S)-4-(anthracen-9-yl)-1-(4-meth­oxy­phen­yl)-2-oxoazetidin-3-yl]-2-aza-2H-phenalene-1,3-dione unknown solvate

Crystal structure of 2-hy­droxy-N-(2-hydroxyethyl)-N-{2-hy­droxy-3-[(E)-N-hydroxyethanimidoyl]-5-methylbenzyl}ethanaminium acetate monohydrate

Crystal structure of methyl (E)-2-(1-methyl-2-oxoindolin-3-yl­idene)acetate

Crystal structure of 2-{[(naphthalen-1-yl)­oxy]meth­yl}-5-(2,4,5-tri­fluoro­phen­yl)-1,3,4-oxa­diazole

Crystal structure of 5,7-di­phenyl-4,7-di­hydro­tetra­zolo[1,5-a]pyrimidine

Crystal structure of 2-methyl­piperazine-1,4-diium bis­(hydrogen maleate)

Crystal structure of ethyl (2S,2′R)-1′-benzyl-3-oxo-3H-di­spiro­[1-benzo­thio­phene-2,3′-pyrrolidine-2′,11′′-indeno[1,2-b]quinoxaline]-4′-carboxyl­ate

Crystal structure of 4,6-di­amino-2-(methyl­sulfan­yl)pyridine-3-carbo­nitrile

Crystal structure of S-hexyl (E)-3-(4-meth­oxy­benzyl­idene)di­thio­carbazate

Crystal structure of 1-{1-[2-(phenyl­selan­yl)phen­yl]-1H-1,2,3-triazol-4-yl}cyclo­hexan-1-ol

Crystal structure of 1-{2-[(2-meth­oxy­phen­yl)selan­yl]phen­yl}-4-phenyl-1H-1,2,3-triazole

Crystal structure of 4-phenyl-1-{2-[(2,4,6-tri­methyl­phen­yl)selan­yl]phen­yl}-1H-1,2,3-triazole

Crystal structure of ethyl 6-methyl-2-oxo-4-(3,4,5-tri­meth­oxy­phen­yl)-1,2,3,4-tetra­hydro­pyrimidine-5-carboxyl­ate

Crystal structure of (E)-2-[1-(1,3-benzodioxol-5-yl)ethyl­idene]-N-ethyl­hydra­zine-1-carbo­thio­amide

Crystal structure of 1-meth­oxy­pyrene

Crystal structure of di­ethyl 2-amino-6-[(thio­phen-3-yl)ethyn­yl]azulene-1,3-di­carboxyl­ate

Crystal structure of 2-benzamido-N-(2,2-di­eth­oxy­eth­yl)benzamide

Crystal structure of the tripeptide N-(benzyl­oxycarbon­yl)glycylglycyl-L-norvaline